The genome and the consumer

Gunna Christiansen

The genome and the consumer

Publikation: Bidrag til tidsskrift › Review (oversigtsartikel) › peer review

Abstract

Consumergenetics has developed so fast that it became possible for consumers to obtain genome risk information based on single nucleotide polymorphisms data of over 250 diseases/conditions for just 99 USD. In November 2013, the American Food and Drug Administration (FDA) ordered the company 23andMe to stop returning health results because they found a lack of scientific evidence of the reposted disease risks. The ethical dilemmas associated with this are reviewed, and the recommendations are described in genome testing. Ethical dilemmas in relation direct-to-consumer testing are discussed.

Originalsprog	Engelsk
Tidsskrift	Ugeskrift for laeger
Vol/bind	176
Udgave nummer	46
Status	Udgivet - 10 nov. 2014
Udgivet eksternt	Ja

Bibliografisk note

Copyright:
This record is sourced from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{b2e7385e9cf3491bbfbd5efd62d31f35,

title = "The genome and the consumer",

abstract = "Consumergenetics has developed so fast that it became possible for consumers to obtain genome risk information based on single nucleotide polymorphisms data of over 250 diseases/conditions for just 99 USD. In November 2013, the American Food and Drug Administration (FDA) ordered the company 23andMe to stop returning health results because they found a lack of scientific evidence of the reposted disease risks. The ethical dilemmas associated with this are reviewed, and the recommendations are described in genome testing. Ethical dilemmas in relation direct-to-consumer testing are discussed. ",

author = "Gunna Christiansen",

note = "Copyright: This record is sourced from MEDLINE{\textregistered}/PubMed{\textregistered}, a database of the U.S. National Library of Medicine",

year = "2014",

month = nov,

day = "10",

language = "English",

volume = "176",

journal = "Ugeskrift for laeger",

issn = "1399-4174",

publisher = "Almindelige Danske Laegeforening",

number = "46",

}

TY - JOUR

T1 - The genome and the consumer

AU - Christiansen, Gunna

N1 - Copyright: This record is sourced from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

PY - 2014/11/10

Y1 - 2014/11/10

N2 - Consumergenetics has developed so fast that it became possible for consumers to obtain genome risk information based on single nucleotide polymorphisms data of over 250 diseases/conditions for just 99 USD. In November 2013, the American Food and Drug Administration (FDA) ordered the company 23andMe to stop returning health results because they found a lack of scientific evidence of the reposted disease risks. The ethical dilemmas associated with this are reviewed, and the recommendations are described in genome testing. Ethical dilemmas in relation direct-to-consumer testing are discussed.

AB - Consumergenetics has developed so fast that it became possible for consumers to obtain genome risk information based on single nucleotide polymorphisms data of over 250 diseases/conditions for just 99 USD. In November 2013, the American Food and Drug Administration (FDA) ordered the company 23andMe to stop returning health results because they found a lack of scientific evidence of the reposted disease risks. The ethical dilemmas associated with this are reviewed, and the recommendations are described in genome testing. Ethical dilemmas in relation direct-to-consumer testing are discussed.

UR - http://www.scopus.com/inward/record.url?scp=85042001719&partnerID=8YFLogxK

M3 - Review article

C2 - 25394929

AN - SCOPUS:85042001719

SN - 1399-4174

VL - 176

JO - Ugeskrift for laeger

JF - Ugeskrift for laeger

IS - 46

ER -

The genome and the consumer

Abstract

Bibliografisk note

AUB Link

Andre filer og links

Fingeraftryk

Citationsformater